LlamaRisk's Oct. 9 snapshots show some Aave loans backed by yield-bearing collateral had narrow liquidation buffers. The top PT-AUSD suppliers on Monad had health factors between 1.01 and 1.18, and two syrupUSDC positions on Arc accounted for about 97% of supplied syrupUSDC, with health factors of 1.02 and 1.01. Cashing out this collateral, such as PT-AUSD or syrupUSDC, involves market sales or withdrawal queues that can take hours, and for Maple's syrupUSDC, up to 30 days, posing challenges for liquidators.